Silvia Scriffignano

684 total citations
49 papers, 430 citations indexed

About

Silvia Scriffignano is a scholar working on Rheumatology, Immunology and Hematology. According to data from OpenAlex, Silvia Scriffignano has authored 49 papers receiving a total of 430 indexed citations (citations by other indexed papers that have themselves been cited), including 44 papers in Rheumatology, 35 papers in Immunology and 21 papers in Hematology. Recurrent topics in Silvia Scriffignano's work include Spondyloarthritis Studies and Treatments (39 papers), Psoriasis: Treatment and Pathogenesis (33 papers) and Autoimmune and Inflammatory Disorders Research (21 papers). Silvia Scriffignano is often cited by papers focused on Spondyloarthritis Studies and Treatments (39 papers), Psoriasis: Treatment and Pathogenesis (33 papers) and Autoimmune and Inflammatory Disorders Research (21 papers). Silvia Scriffignano collaborates with scholars based in Italy, Belgium and United Kingdom. Silvia Scriffignano's co-authors include Fabio Massimo Perrotta, Ennio Lubrano, Francesco Ciccia, Juan D. Cañete, Julio Ramírez, Mario Ronga, Maria Sole Chimenti, Philip Helliwell, Laura C. Coates and Paola Triggianese and has published in prestigious journals such as SHILAP Revista de lepidopterología, Frontiers in Immunology and Annals of the Rheumatic Diseases.

In The Last Decade

Silvia Scriffignano

44 papers receiving 422 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Silvia Scriffignano Italy 13 368 290 161 31 29 49 430
Nick Barkham United Kingdom 10 512 1.4× 315 1.1× 171 1.1× 22 0.7× 18 0.6× 25 563
Bassel Elzorkany Egypt 8 327 0.9× 164 0.6× 127 0.8× 20 0.6× 21 0.7× 25 390
Cristina Fernández‐Carballido Spain 12 311 0.8× 210 0.7× 108 0.7× 14 0.5× 15 0.5× 50 384
Nicolò Girolimetto Italy 12 335 0.9× 257 0.9× 138 0.9× 7 0.2× 28 1.0× 26 393
Maxime Dougados France 6 390 1.1× 202 0.7× 144 0.9× 11 0.4× 20 0.7× 7 453
Anna Deminger Sweden 8 297 0.8× 132 0.5× 54 0.3× 21 0.7× 76 2.6× 16 356
D. Ruiz Spain 7 148 0.4× 100 0.3× 44 0.3× 8 0.3× 37 1.3× 29 256
Mazen Abdellatif United States 4 304 0.8× 117 0.4× 91 0.6× 6 0.2× 15 0.5× 8 425
J Medich United States 3 394 1.1× 333 1.1× 233 1.4× 11 0.4× 9 0.3× 4 475
Jenny Griffith United States 12 123 0.3× 95 0.3× 60 0.4× 19 0.6× 19 0.7× 39 286

Countries citing papers authored by Silvia Scriffignano

Since Specialization
Citations

This map shows the geographic impact of Silvia Scriffignano's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Silvia Scriffignano with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Silvia Scriffignano more than expected).

Fields of papers citing papers by Silvia Scriffignano

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Silvia Scriffignano. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Silvia Scriffignano. The network helps show where Silvia Scriffignano may publish in the future.

Co-authorship network of co-authors of Silvia Scriffignano

This figure shows the co-authorship network connecting the top 25 collaborators of Silvia Scriffignano. A scholar is included among the top collaborators of Silvia Scriffignano based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Silvia Scriffignano. Silvia Scriffignano is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Perrotta, Fabio Massimo, Rossana Scrivo, Salvatore D’Angelo, et al.. (2024). Assessment of Patient–Physician Interactions in Psoriatic Arthritis: National Results of the ASSIST Study. Rheumatology and Therapy. 11(3). 553–562. 1 indexed citations
2.
Lubrano, Ennio, Silvia Scriffignano, & Fabio Massimo Perrotta. (2024). Clinical Characteristics of “Severe” Peripheral Psoriatic Arthritis: A Retrospective Analysis of a Longitudinal Cohort. Rheumatology and Therapy. 11(3). 663–674.
3.
Manara, M., Mattia Congia, Marco Pandolfi, et al.. (2024). Non-steroidal anti-inflammatory drugs in psoriatic arthritis: clinical practice suggestions based on scientific evidence and expert opinion.. Clinical and Experimental Rheumatology. 43(5). 897–906.
4.
Lubrano, Ennio, Silvia Scriffignano, & Fabio Massimo Perrotta. (2023). Patient reported outcomes in early vs late diagnosis of psoriatic arthritis. Revista Colombiana de Reumatología. 30. S27–S33. 1 indexed citations
5.
Lubrano, Ennio, Silvia Scriffignano, Kurt de Vlam, et al.. (2023). Triple jump for the optimal management of psoriatic arthritis: diet, sleep and exercise – a review. RMD Open. 9(3). e003339–e003339. 12 indexed citations
6.
Lubrano, Ennio, Silvia Scriffignano, & Fabio Massimo Perrotta. (2023). Difficult to Treat and Refractory to Treatment in Psoriatic Arthritis. Rheumatology and Therapy. 10(5). 1119–1125. 16 indexed citations
7.
8.
Perrotta, Fabio Massimo, Mario Ronga, Silvia Scriffignano, & Ennio Lubrano. (2023). Ultrasonographic Evaluation of Entheseal Fibrocartilage in Patients with Psoriatic Arthritis, Athletes and Healthy Controls: A Comparison Study. Diagnostics. 13(8). 1446–1446. 3 indexed citations
9.
McGonagle, Dennis, et al.. (2023). A strategy towards disentangling treatment refractory from misdiagnosed axial Spondyloarthritis. Autoimmunity Reviews. 23(1). 103405–103405. 7 indexed citations
10.
Lubrano, Ennio, et al.. (2023). Psoriatic Arthritis in Males and Females: Differences and Similarities. Rheumatology and Therapy. 10(3). 589–599. 27 indexed citations
11.
Perrotta, Fabio Massimo, Silvia Scriffignano, Francesco Ciccia, & Ennio Lubrano. (2022). Clinical Characteristics of Potential “Difficult-to-treat” Patients with Psoriatic Arthritis: A Retrospective Analysis of a Longitudinal Cohort. Rheumatology and Therapy. 9(4). 1193–1201. 34 indexed citations
12.
Perrotta, Fabio Massimo, Silvia Scriffignano, Francesco Ciccia, & Ennio Lubrano. (2022). Therapeutic Targets for Ankylosing Spondylitis – Recent Insights and Future Prospects. Dove Medical Press (Taylor and Francis Group). 6 indexed citations
13.
Scriffignano, Silvia, et al.. (2022). Women in rheumatology: major contributions and key discoveries of the twentieth century. Lara D. Veeken. 62(1). 29–34.
14.
Lubrano, Ennio, Silvia Scriffignano, & Fabio Massimo Perrotta. (2022). Sequencing of Biologic and Target Synthetic Disease-Modifying Anti-Rheumatic Drugs in Psoriatic Arthritis: Are we Ready to Redefine the Treatment Strategy? A Perspective. Rheumatology and Therapy. 10(2). 301–306. 6 indexed citations
15.
16.
Lubrano, Ennio, Silvia Scriffignano, & Fabio Massimo Perrotta. (2020). Multimorbidity and comorbidity in psoriatic arthritis – a perspective. Expert Review of Clinical Immunology. 16(10). 963–972. 23 indexed citations
17.
Lubrano, Ennio, et al.. (2020). Impact of Comorbidities on Disease Activity, Patient Global Assessment, and Function in Psoriatic Arthritis: A Cross-Sectional Study. Rheumatology and Therapy. 7(4). 825–836. 21 indexed citations
18.
Perrotta, Fabio Massimo, et al.. (2019). Occult axial involvement in patients with psoriatic arthritis mutilans: a case report. Reumatismo. 71(2). 88–91. 1 indexed citations
19.
Scriffignano, Silvia, et al.. (2018). Role of comorbidities in spondyloarthritis including psoriatic arthritis. Clinical Rheumatology. 38(1). 3–10. 28 indexed citations
20.
Lubrano, Ennio, Silvia Scriffignano, & Fabio Massimo Perrotta. (2018). Abatacept for the treatment of psoriatic arthritis. Expert Review of Clinical Immunology. 14(11). 899–905. 7 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Nick Barkham Breakdown of academic impact, for papers by Bassel Elzorkany Breakdown of academic impact, for papers by Cristina Fernández‐Carballido Breakdown of academic impact, for papers by Nicolò Girolimetto Breakdown of academic impact, for papers by Maxime Dougados Breakdown of academic impact, for papers by Anna Deminger Breakdown of academic impact, for papers by D. Ruiz Breakdown of academic impact, for papers by Mazen Abdellatif Breakdown of academic impact, for papers by J Medich Breakdown of academic impact, for papers by Jenny Griffith
Rankless by CCL
2026